Certain medications that reduce the risk of breast cancer now must be covered under Obamacare.
The Department of Health and Human Services issued guidance Thursday saying that most insurance plans are required to cover the chemo-preventative drugs tamoxifen and raloxifene without co-pays or out-of-pocket expenses for women with an increased risk of developing breast cancer.
The Obama administration issued the clarification after questions arose about whether these medications count as preventative care, HHS Secretary Kathleen Sebelius and Florida Democratic Rep. Debbie Wasserman Schultz — a breast cancer survivor — wrote in a blog post Thursday.
The United States Preventive Services Task Force, an independent panel of experts selected by HHS, revised its recommendation in September to suggest the medications be available to women at high risk for the disease.
There is an exception to HHS’ policy, however: Grandfathered plans — those that existed prior to the passage of the Affordable Care Act — are not subject to the same requirements.
The National Cancer Institute estimates that in 2013 there were 232,340 new cases of breast cancer in women, and 2,240 in men. Cause and prevention of breast cancer in men is currently less well understood.
Preventative screening is a point of emphasis for the Affordable Care Act, as the law aims to promote such treatments in a bid to cut total health spending. But what treatments and medications meet the law’s criteria for preventative care — and which ones get an inclusion mandate in insurance plans — is a point of contention for various medical constituencies trying to get their treatments under Obamacare’s umbrella.
What We're Following See More »
The House Intelligence Committee voted to release the November 14 testimony of Glenn Simpson, the man at Fusion GPS who oversaw the creation of the now infamous Trump-Russia dossier. Simpson's testimony includes a number of startling claims, including that Russia infiltrated conservative political groups prior to the election, and that Trump had "long time associations" with the Italian Mafia," and that he "gradually during the nineties became associated with Russian mafia figures." Simpson also testified that Trump called off a post-election meeting with Alexander Torshin, the deputy governor of Russia’s central bank and a longtime member of the NRA, currently under investigation by the FBI for money laundering. Simpson said that the discoveries were so alarming that he felt compelled to go to the authorities. The full text of the transcript can be read here.
House Speaker Paul Ryan says he has the votes to pass a short-term spending bill tonight, but "Senate Democrats said they're confident they have the votes to block the stop-gap spending bill that the House is taking up, according to two Democratic senators and a senior party aide. And top Senate Republicans are openly worried about the situation as they struggle to keep their own members in the fold."
"The FBI is investigating whether a top Russian banker with ties to the Kremlin illegally funneled money to the National Rifle Association to help Donald Trump win the presidency." Investigators have focused on Alexander Torshin, the deputy governor of Russia’s central bank "who is known for his close relationships with both Russian President Vladimir Putin and the NRA." The solicitation or use of foreign funds is illegal in U.S. elections under the Federal Election Campaign Act (FECA) by either lobbying groups or political campaigns. The NRA reported spending a record $55 million on the 2016 elections.
"Hundreds of new and supplemental FARA filings by U.S. lobbyists and public relations firms" have been submitted "since Special Counsel Mueller charged two Trump aides with failing to disclose their lobbying work on behalf of foreign countries. The number of first-time filings ... rose 50 percent to 102 between 2016 and 2017, an NBC News analysis found. The number of supplemental filings, which include details about campaign donations, meetings and phone calls more than doubled from 618 to 1,244 last year as lobbyists scrambled to avoid the same fate as some of Trump's associates and their business partners."